ArticleOncology letters2025

Utidelone combined with anti‑angiogenic therapy for the treatment of anthracycline/taxane‑treated and endocrine‑resistant HR

Xue Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.